PharmaCons PHVC SRL is a privately held pharmacovigilance services company operating under the brand PhVC — with the tagline “Safety First” — and incorporated as a Romanian legal entity (SRL). The company is contactable via its website at pharmacons-phvc.com and positions itself as a dedicated pharmacovigilance outsourcing partner for pharmaceutical marketing authorisation holders and sponsors seeking specialist drug safety expertise on a flexible, cost-variable basis.

The company’s service model is built explicitly around the outsourcing of specialist pharmacovigilance functions — converting fixed internal resource costs into variable, workload-dependent charges — enabling pharmaceutical companies to access dedicated, qualified pharmacovigilance staff without the overhead of maintaining a full in-house safety team. Its stated focus is on building pragmatic and compliant pharmacovigilance systems across the full product lifecycle, with a particular emphasis on meeting EU legislative requirements under the revised pharmacovigilance legislation (Directive 2010/84/EU and Regulation (EU) No 1235/2010), GVP modules, and EMA guidance.

Beyond specific service lines, limited public information is available about the company’s founding date, employee count, or client portfolio. The website was last materially updated in 2017 based on WordPress version metadata, suggesting a relatively lean online presence relative to its operational scope.

Key Products and Services

Management of Individual Case Safety Reports (ICSRs)

• Receipt, triage, data entry, medical assessment, coding (MedDRA), narrative writing, and submission of Individual Case Safety Reports to EudraVigilance and national competent authorities within EU expedited reporting timelines
• Case management across spontaneous reports, literature cases, solicited reports, and clinical trial safety reports
• Quality control and completeness follow-up on received ICSRs

Signal Detection and Ongoing Safety Evaluation

• Systematic signal detection from spontaneous reporting databases, literature, and other data sources using quantitative and qualitative methods
• Ongoing benefit-risk assessment and safety monitoring across the product lifecycle
• Signal evaluation, prioritisation, and regulatory communication management

Safety Evaluation Reports

• Periodic Safety Update Reports (PSURs) and Periodic Benefit-Risk Evaluation Reports (PBRERs) preparation and submission to EMA and national competent authorities within regulatory timelines
• Risk Management Plans (RMPs) — preparation, maintenance, and updating of EU RMPs aligned with GVP Module V requirements
• Clinical Expert Statements (CES) for regulatory submission packages

Safety Data Exchange Agreements (SDEAs)

• Design, negotiation support, and management of SDEAs between marketing authorisation holders, licence partners, distributors, and other relevant parties, establishing clear adverse event reporting obligations and timelines across commercial arrangements

Pharmacovigilance System Master File (PSMF) Support

• Preparation, maintenance, and updating of the Pharmacovigilance System Master File to GVP Module II requirements, ensuring audit readiness and regulatory compliance
• Gap assessment and remediation support for existing PSMF documentation

PharmaCons PhVC occupies the specialist pharmacovigilance outsourcing segment of the European contract services market, targeting pharmaceutical marketing authorisation holders — particularly smaller and mid-sized companies — that require compliant, flexible drug safety system support without the cost of a fully staffed in-house pharmacovigilance function. Its Romanian base positions it as a cost-competitive EU-member-state provider with direct alignment to EMA regulatory requirements and EudraVigilance reporting obligations, making it a credible option for European-market pharmaceutical clients. The company’s service portfolio covers the core mandatory pharmacovigilance obligations under EU legislation — ICSR management, aggregate reporting, signal detection, PSMF maintenance, and SDEA management — providing a functionally complete outsourcing offer for companies seeking to delegate their EU pharmacovigilance obligations to a specialist third party. The limited public profile and a website last updated in 2017 suggest a boutique operation with modest commercial scale.